We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VIRP.PA

Price
302.00
Stock movement down
-4.00 (-1.31%)
Company name
Virbac SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
2.53B
Ent value
3.17B
Price/Sales
1.30
Price/Book
2.54
Div yield
-
Div growth
-
Growth years
-
FCF payout
37.36%
Trailing P/E
11.71
Forward P/E
15.23
PEG
-
EPS growth
43.21%
1 year return
-16.11%
3 year return
-5.11%
5 year return
10.68%
10 year return
3.72%
Last updated: 2025-04-18

DIVIDENDS

VIRP.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E11.71
Price to OCF15.43
Price to FCF33.99
Price to EBITDA5.57
EV to EBITDA6.99

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.30
Price to Book2.54
EV to Sales1.63

FINANCIALS

Per share

Loading...
Per share data
Current share count8.37M
EPS (TTM)25.76
FCF per share (TTM)8.88

Income statement

Loading...
Income statement data
Revenue (TTM)1.95B
Gross profit (TTM)1.10B
Operating income (TTM)319.79M
Net income (TTM)215.97M
EPS (TTM)25.76
EPS (1y forward)19.83

Margins

Loading...
Margins data
Gross margin (TTM)56.53%
Operating margin (TTM)16.40%
Profit margin (TTM)11.08%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash156.86M
Net receivables222.60M
Total current assets877.29M
Goodwill314.26M
Intangible assets185.15M
Property, plant and equipment0.00
Total assets1.80B
Accounts payable138.11M
Short/Current long term debt407.00M
Total current liabilities530.63M
Total liabilities801.99M
Shareholder's equity994.24M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)163.94M
Capital expenditures (TTM)77.52M
Free cash flow (TTM)74.41M
Dividends paid (TTM)27.80M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity21.72%
Return on Assets12.02%
Return on Invested Capital18.12%
Cash Return on Invested Capital6.24%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open302.10
Daily high304.45
Daily low300.20
Daily Volume9K
All-time high443.00
1y analyst estimate402.94
Beta0.97
EPS (TTM)25.76
Dividend per share-
Ex-div date25 Jun 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
VIRP.PAS&P500
Current price drop from All-time high-31.83%-14.12%
Highest price drop-62.10%-56.47%
Date of highest drop13 Apr 19999 Mar 2009
Avg drop from high-21.80%-11.07%
Avg time to new high31 days12 days
Max time to new high2000 days1805 days
COMPANY DETAILS
VIRP.PA (Virbac SA) company logo
Marketcap
2.53B
Marketcap category
Mid-cap
Description
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Employees
5459
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope KEY FIGURESRevenue1st quarter 2025€375.2MGrowth at constant exchange rates and scope1+4.9% of ...
April 15, 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
April 9, 2025
Very strong revenues increase of 13.6% at constant exchange rates, driven by: dynamic organic growth (+7.5%) strategic contribution of our acquisitions (+6.1%) 2024 operating income2 at an all-time hi...
March 13, 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
March 7, 2025
Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%) Press release issued on January 16, 2025 after market clos...
January 16, 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
January 10, 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
December 6, 2024
On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products. Present in Türkiye for over 20 years via various...
December 3, 2024
Virbac(ENXTPA:VIRP) has recently raised its earnings guidance for fiscal year 2024, anticipating net revenue growth between 12.5% and 14.5%, bolstered by strategic acquisitions of Globion and Sasaeah....
November 10, 2024
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
November 6, 2024
Next page